Skip to content

13F-HR filed by Knoll Capital Management, LLC

Knoll Capital Management, LLC filed this 13F-HR for the quarter ended 2024-12-31, filed 2025-02-18, with 35 holding rows worth $155,344,595.

Accession
0001104659-25-014391
Filed
2025-02-18
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q4 2024

A holdings report, 35 entries on the cover page, a total value of $155,344,595 stated on the cover page (in dollars after the unit check, H1), rows summing to $155,344,595 with VALUE read as dollars as filed, 13F file number 028-11424. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
BIOHAVEN PHARMACEUTICAL HOLDING11196105COM760,422$28,401,761dollars as filed
ALDEYRA THERAPEUTICS INC01438T106COM5,475,516$27,322,824dollars as filed
ENTERA BIO LTDM40527109SHS5,881,879$12,469,583dollars as filed
VERONA PHARMA PLC925050106SPONSORED ADS200,000$9,288,000dollars as filed
ALTIMMUNE INC02155H200COM NEW1,121,524$8,086,188dollars as filed
SPDR GOLD TR78463V107GOLD SHS32,000$7,748,160dollars as filed
MEIRAGTX HOLDINGS PLCG59665102COMMON STOCK1,250,000$7,612,500dollars as filed
AVADEL PHARMACEUTICALS, PLC05337M104COMMON STOCK-FO600,000$6,306,000dollars as filed
OCULAR THERAPEUTIX INC67576A100COM600,400$5,127,416dollars as filed
Applied Therapeutics Inc03828A101Common Stock5,799,687$4,964,532dollars as filed
AGNICO EAGLE MINES LTD COM008474108Stock55,500$4,340,655dollars as filed
KINROSS GOLD CORP496902404COM440,000$4,078,800dollars as filed
SEABRIDGE GOLD INC811916105COM *D*317,003$3,617,004dollars as filed
FRANCO NEV CORP COM351858105Stock25,000$2,939,750dollars as filed
EQUINOX GOLD CORP29446Y502COM550,811$2,765,071dollars as filed
SKEENA RES LTD NEW83056P715COM315,400$2,750,288dollars as filed
MAG SILVER CORP55903Q104COMMON STOCK-FO170,000$2,312,000dollars as filed
iShares Silver Trust46428Q109COM80,000$2,106,400dollars as filed
BOOZ ALLEN HAMILTON HLDG CORP CL A099502106Stock13,000$1,673,100dollars as filed
Visa Inc92826C839COM4,850$1,532,794dollars as filed
Philip Morris International Inc.718172109COM10,000$1,203,500dollars as filed
iShares U.S. Aerospace & Defense ETF464288760SHS7,650$1,111,927dollars as filed
NORTHROP GRUMMAN CORP COM666807102Stock2,165$1,016,012dollars as filed
HOOKIPA PHARMA INC43906K100COM498,625$1,002,236dollars as filed
ROYAL GOLD INC780287108COM7,550$995,467dollars as filed
MEREO BIOPHARMA GROUP PLC589492107CMN260,470$911,645dollars as filed
DIAGEO PLC SPON ADR NEW25243Q205ADR6,750$858,127dollars as filed
ALAMOS GOLD INC COM CL A011532108Stock41,000$756,040dollars as filed
WHEATON PRECIOUS METALS CORP COM962879102Stock12,500$703,000dollars as filed
NEW PAC METALS CORP64782A107COM485,000$572,300dollars as filed
SILVERCREST METALS INC828363101COM60,000$546,000dollars as filed
CARDIOL THERAPEUTICS INC14161Y200COM CL A100,000$128,000dollars as filed
Orgenesis, Inc.68619K105COM50,623$95,677dollars as filed
GRAIL INC384747101COM100$1,785dollars as filed
OPUS GENETICS INC67577R102COMMON STOCK45$53dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001104659-25-014391this filing2025-02-18acceptance time not in the bulk data set